Mulroy Michael H. 4
4 · Asterias Biotherapeutics, Inc. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Mulroy Michael H.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2019-03-01+252,606→ 350,210 total - Tax Payment
Common Stock
2019-03-01$0.95/sh−76,588$72,759→ 273,622 total
Holdings
- 200,000
Stock Options
Exercise: $1.95Exp: 2028-03-14→ Common Stock (200,000 underlying) - 800,000
Stock Options
Exercise: $3.70Exp: 2027-06-25→ Common Stock (800,000 underlying)
Footnotes (4)
- [F1]The shares reported herein were awarded to the Reporting Person by the Issuer's Board of Directors upon recommendation by the Compensation Committee, in connection with the Company's 2018 bonus payment to the Reporting Person, in lieu of cash payment to the Reporting Person.
- [F2]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the grant of shares reported herein.
- [F3]Subject to Mr. Mulroy's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was March 14, 2018. The stock options are exercisable upon vesting.
- [F4]Subject to Mr. Mulroy's continued employment with the Company, the stock options vest in equal monthly installments over 48 months commencing on July 31, 2017. The stock options are exercisable upon vesting.